Keywords: LoneStar Heart, Possible diabetes treatments, UT Southwestern, Isoxazole

LoneStar Heart gets rights to possible diabetes treatments

Article | 18 January 2012

LoneStar Heart, a USA-based developer of proprietary biopolymer, small molecule and cellular-based therapies to effectively treat heart failure and other ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

LoneStar Heart

Go to company listing